loading
Edwards Lifesciences Corp stock is traded at $83.24, with a volume of 2.00M. It is up +0.67% in the last 24 hours and up +7.03% over the past month. Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
See More
Previous Close:
$82.69
Open:
$82.95
24h Volume:
2.00M
Relative Volume:
0.47
Market Cap:
$48.87B
Revenue:
$5.69B
Net Income/Loss:
$1.41B
P/E Ratio:
11.92
EPS:
6.9828
Net Cash Flow:
$577.90M
1W Performance:
+8.77%
1M Performance:
+7.03%
6M Performance:
+10.27%
1Y Performance:
+21.29%
1-Day Range:
Value
$82.35
$83.71
1-Week Range:
Value
$75.48
$84.66
52-Week Range:
Value
$64.89
$84.66

Edwards Lifesciences Corp Stock (EW) Company Profile

Name
Name
Edwards Lifesciences Corp
Name
Phone
(949) 250-2500
Name
Address
ONE EDWARDS WAY, IRVINE, CA
Name
Employee
15,800
Name
Twitter
@edwardslifesci
Name
Next Earnings Date
2025-02-11
Name
Latest SEC Filings
Name
EW's Discussions on Twitter

Compare EW with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
EW
Edwards Lifesciences Corp
83.25 48.55B 5.69B 1.41B 577.90M 6.9828
Medical Devices icon
ABT
Abbott Laboratories
124.93 216.57B 43.84B 13.94B 6.78B 7.9979
Medical Devices icon
BSX
Boston Scientific Corp
101.42 148.62B 19.35B 2.78B 3.49B 1.8696
Medical Devices icon
SYK
Stryker Corp
370.52 141.30B 23.82B 2.92B 4.02B 7.5574
Medical Devices icon
MDT
Medtronic Plc
91.48 117.65B 34.20B 4.69B 5.30B 3.6218

Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-08-25 Downgrade Oppenheimer Outperform → Perform
Oct-07-25 Upgrade Evercore ISI In-line → Outperform
Jul-29-25 Upgrade BTIG Research Neutral → Buy
Apr-24-25 Upgrade Piper Sandler Neutral → Overweight
Jan-30-25 Upgrade Stifel Hold → Buy
Jan-16-25 Downgrade Wolfe Research Peer Perform → Underperform
Dec-16-24 Upgrade BofA Securities Neutral → Buy
Oct-11-24 Resumed Morgan Stanley Equal-Weight
Sep-18-24 Downgrade Jefferies Buy → Hold
Jul-31-24 Upgrade Daiwa Securities Neutral → Outperform
Jul-29-24 Upgrade Wolfe Research Underperform → Peer Perform
Jul-25-24 Downgrade BofA Securities Buy → Neutral
Jul-25-24 Downgrade JP Morgan Overweight → Neutral
Jul-25-24 Downgrade Robert W. Baird Outperform → Neutral
Jul-25-24 Downgrade TD Cowen Buy → Hold
Jul-25-24 Downgrade Truist Buy → Hold
May-30-24 Initiated Goldman Buy
May-22-24 Upgrade Citigroup Neutral → Buy
May-14-24 Upgrade Deutsche Bank Hold → Buy
Mar-07-24 Upgrade BofA Securities Neutral → Buy
Feb-02-24 Upgrade Wells Fargo Equal Weight → Overweight
Jan-04-24 Downgrade Evercore ISI Outperform → In-line
Dec-11-23 Downgrade Citigroup Buy → Neutral
Nov-28-23 Downgrade Wolfe Research Peer Perform → Underperform
Sep-26-23 Upgrade Oppenheimer Perform → Outperform
Jul-19-23 Initiated Robert W. Baird Outperform
May-30-23 Resumed Morgan Stanley Overweight
Mar-29-23 Initiated UBS Neutral
Mar-08-23 Downgrade Wells Fargo Overweight → Equal Weight
Feb-06-23 Downgrade Raymond James Outperform → Mkt Perform
Jan-31-23 Downgrade Bernstein Outperform → Underperform
Jan-30-23 Downgrade Piper Sandler Overweight → Neutral
Dec-06-22 Downgrade Stifel Buy → Hold
Oct-28-22 Downgrade Oppenheimer Outperform → Perform
Oct-26-22 Initiated Mizuho Buy
Oct-18-22 Initiated Barclays Overweight
Oct-12-22 Initiated Jefferies Buy
Jul-29-22 Downgrade Canaccord Genuity Buy → Hold
Apr-13-22 Initiated Truist Buy
Apr-06-22 Initiated Wolfe Research Outperform
Mar-16-22 Upgrade Bernstein Mkt Perform → Outperform
Mar-02-22 Resumed BofA Securities Neutral
Feb-02-22 Upgrade UBS Neutral → Buy
Jan-27-22 Reiterated Citigroup Buy
Jan-27-22 Reiterated Evercore ISI Outperform
Jan-27-22 Reiterated Raymond James Outperform
Jan-27-22 Reiterated Stifel Buy
Jan-27-22 Reiterated UBS Neutral
Dec-17-21 Upgrade JP Morgan Neutral → Overweight
Dec-15-21 Upgrade Citigroup Neutral → Buy
Dec-10-21 Initiated RBC Capital Mkts Outperform
Dec-06-21 Upgrade Wells Fargo Equal Weight → Overweight
Jul-30-21 Reiterated Canaccord Genuity Buy
Jul-30-21 Reiterated Deutsche Bank Hold
Jul-30-21 Reiterated Jefferies Buy
Jul-30-21 Reiterated Morgan Stanley Overweight
Jul-30-21 Reiterated Oppenheimer Outperform
Jul-30-21 Reiterated Stifel Buy
Jul-30-21 Reiterated UBS Neutral
Jul-30-21 Reiterated Wells Fargo Equal Weight
May-25-21 Initiated Barclays Overweight
Apr-15-21 Initiated Atlantic Equities Neutral
Apr-05-21 Upgrade Evercore ISI In-line → Outperform
Dec-16-20 Downgrade Citigroup Buy → Neutral
Dec-11-20 Reiterated Canaccord Genuity Buy
Sep-11-20 Initiated Wolfe Research Underperform
Apr-28-20 Downgrade Wells Fargo Overweight → Equal Weight
Apr-17-20 Upgrade SVB Leerink Mkt Perform → Outperform
Mar-05-20 Initiated Citigroup Buy
Feb-13-20 Initiated Goldman Neutral
Feb-06-20 Resumed BTIG Research Neutral
Jan-10-20 Initiated Oppenheimer Outperform
Jan-02-20 Downgrade Evercore ISI Outperform → In-line
Oct-24-19 Reiterated Canaccord Genuity Buy
Sep-23-19 Initiated Piper Jaffray Overweight
Jul-24-19 Reiterated BofA/Merrill Buy
Mar-18-19 Reiterated Canaccord Genuity Buy
Jan-18-19 Upgrade BofA/Merrill Neutral → Buy
Jan-03-19 Initiated Deutsche Bank Hold
Nov-28-18 Initiated UBS Neutral
Oct-16-18 Initiated Barclays Underweight
Oct-02-18 Downgrade BofA/Merrill Buy → Neutral
Oct-02-18 Downgrade Guggenheim Buy → Neutral
View All

Edwards Lifesciences Corp Stock (EW) Latest News

pulisher
07:10 AM

Econ Financial Services Corp Makes New $889,000 Investment in Edwards Lifesciences Corporation $EW - MarketBeat

07:10 AM
pulisher
06:10 AM

Jennison Associates LLC Raises Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat

06:10 AM
pulisher
04:30 AM

What is the fair value of Edwards Lifesciences Corporation stock nowWeekly Market Summary & Real-Time Price Movement Reports - newser.com

04:30 AM
pulisher
03:31 AM

Quantitative breakdown of Edwards Lifesciences Corporation recent moveQuarterly Portfolio Report & Weekly Setup with ROI Potential - newser.com

03:31 AM
pulisher
01:55 AM

How Edwards Lifesciences Corporation (EWL) stock responds to bond marketJuly 2025 Intraday Action & Free AI Powered Buy and Sell Recommendations - newser.com

01:55 AM
pulisher
Oct 29, 2025

Why Edwards Lifesciences (EW) Is Up 7.6% After Positive Long-Term Data for SAPIEN Valve Platform - Yahoo Finance

Oct 29, 2025
pulisher
Oct 29, 2025

Why Analysts Say Edwards Lifesciences Story Is Evolving With New Data and Market Shifts - Yahoo Finance

Oct 29, 2025
pulisher
Oct 29, 2025

Edwards Lifesciences (NYSE:EW) Market Activity and S&P 500 Futures - Kalkine Media

Oct 29, 2025
pulisher
Oct 29, 2025

Edwards Lifesciences Corp. Experiences Evaluation Revision Amid Mixed Market Performance Indicators - Markets Mojo

Oct 29, 2025
pulisher
Oct 29, 2025

Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Truist Financial Analyst Says - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

Wolfe Research Upgrades Edwards Lifesciences (EW) Rating to 'Pee - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

Edwards Lifesciences (EW) Receives Upgrade to 'Buy' from Jefferies | EW Stock News - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

This Edwards Lifesciences Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday - Benzinga

Oct 29, 2025
pulisher
Oct 29, 2025

Is Edwards Lifesciences Corporation (EWL) stock resilient in recession scenarios2025 Top Gainers & Trade Opportunity Analysis - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Teacher Retirement System of Texas Boosts Stake in Edwards Lifesciences Corporation $EW - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

Using data models to predict Edwards Lifesciences Corporation stock movement2025 Major Catalysts & Capital Efficiency Focused Strategies - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Why Edwards Lifesciences Corporation stock is a must watch in 20252025 Volatility Report & AI Enhanced Market Trend Forecasts - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Truist Securities Raises Price Target for Edwards Lifesciences (EW) | EW Stock News - GuruFocus

Oct 28, 2025
pulisher
Oct 28, 2025

Data from Partner 3 low-risk affirms TAVR even with SAVR - BioWorld MedTech

Oct 28, 2025
pulisher
Oct 28, 2025

Edwards Lifesciences stock price target raised to $87 by Truist on positive trial data - Investing.com

Oct 28, 2025
pulisher
Oct 28, 2025

Truist Raises Price Target on Edwards Lifesciences to $87 From $82, Keeps Hold Rating - MarketScreener

Oct 28, 2025
pulisher
Oct 28, 2025

Edwards Lifesciences Corporation stock trend forecastWeekly Market Summary & Expert Approved Momentum Ideas - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Will Edwards Lifesciences Corporation stock return to pre crash levels2025 Dividend Review & Fast Entry Momentum Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

How robust is Edwards Lifesciences Corporation (EWL) stock financial positionWeekly Profit Summary & Free Weekly Watchlist of Top Performers - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Edwards SAPIEN 3 TAVR Delivers Proven Long-term Benefits and Valve Performance, New Data Presented at TCT 2025 - BioSpace

Oct 28, 2025
pulisher
Oct 28, 2025

What dividend safety score for Edwards Lifesciences Corporation stock2025 Earnings Surprises & Technical Buy Zone Confirmations - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Using Python tools to backtest Edwards Lifesciences Corporation strategiesMarket Performance Summary & AI Forecasted Entry and Exit Points - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

EW Investor News: Rosen Law Firm Investigates Breaches of - GlobeNewswire

Oct 27, 2025
pulisher
Oct 27, 2025

PATENT—Fed. Cir.: Noninfringement ruling for Edwards Lifesciences in heart valve patent suit affirmed on appeal - VitalLaw.com

Oct 27, 2025
pulisher
Oct 27, 2025

Edwards Lifesciences’ INNOVALVE System: A Promising Step in Mitral Valve Treatment - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Is Edwards Lifesciences Corporation stock cheap by valuation metricsWeekly Investment Report & Weekly Watchlist of Top Performers - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Edwards Lifesciences’ PROGRESS Trial: A Game-Changer in Aortic Stenosis Treatment? - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Edwards Lifesciences’ New Study on Continuous Blood Pressure Monitoring: What Investors Should Know - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Edwards Lifesciences’ ALT-FLOW II Trial: A New Hope for Heart Failure Treatment? - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Edwards Lifesciences’ PASCAL System: A Pivotal Study Update - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Edwards Lifesciences reports positive outcomes for heart valve therapies - Investing.com

Oct 27, 2025
pulisher
Oct 27, 2025

Edwards Lifesciences Advances Monitoring Tech with New Study - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Edwards Lifesciences’ ENCIRCLE Trial: A New Hope for Mitral Regurgitation Patients - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Edwards Lifesciences’ MITRIS Valve Study: A Potential Game-Changer in Mitral Valve Replacement - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch

Oct 27, 2025
pulisher
Oct 27, 2025

Edwards Lifesciences (EW) Sees Positive Movement After Trial Dat - GuruFocus

Oct 27, 2025
pulisher
Oct 27, 2025

Edwards Lifesciences’ Real-World Study on INSPIRIS RESILIA Aortic Valve: A Market Game Changer? - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Data backs Edwards Evoque, Sapien M3 tricuspid, mitral valves - MassDevice

Oct 27, 2025
pulisher
Oct 27, 2025

Edwards Lifesciences Stock Climbs Amid Clinical Trials - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Edwards shares superior long-term outcomes from TAVR studies - MassDevice

Oct 27, 2025
pulisher
Oct 27, 2025

Successful Patient Outcomes Demonstrated With Edwards’ SAPIEN M3 and EVOQUE Systems, New Data Presented at TCT 2025 - Yahoo Finance

Oct 27, 2025
pulisher
Oct 27, 2025

Edwards Lifesciences’ SAPIEN X4 Study: A Potential Game-Changer in Heart Valve Treatment - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Edwards Lifesciences Explores Personalized Blood Pressure Targets in New Study - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Edwards Lifesciences’ ALTERRA Study: A Potential Game-Changer in Heart Valve Treatment - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Edwards Lifesciences’ MiCLASP Study: A Key Update for Investors - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Edwards TAVR shows equivalent outcomes to surgery at seven years - Investing.com

Oct 27, 2025

Edwards Lifesciences Corp Stock (EW) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$76.02
price down icon 1.61%
$68.20
price up icon 0.00%
medical_devices PHG
$27.38
price down icon 0.76%
medical_devices STE
$236.92
price up icon 0.22%
$314.18
price down icon 0.75%
Cap:     |  Volume (24h):